Abstracting and Indexing

Scopus, Chemical Abstracts, CAB abstracts, Hinari, Global Health, EBSCO Publishing's Electronic Databases, Summon by serial solutions, Abstracts on Hygiene and Communicable Diseases, Proquest, Tropical Diseases Bulletin, Open j-Gate, Google Scholar, Science Central, Ulrich's Periodicals Directory, Scimago Journal Ranking, AYUSH Research Portal, Geneva Foundation for Medical Education and Research, ABC Chemistry, Biblioteca, Necker, Academic Journals Database, InfoTrac Custom & Academic Onefile (Gale), Index Medicus for South-East Asia Region (IMSEAR), CNKI scholar.

News & Events

  • JAPS is approved by UGC.
  • JAPS has implemented the CrossMark, a multi-publisher initiative from CrossRef for forthcoming articles [Read more]
  • All the contents published in JAPS are archived in Portico, which provides permanent digital archiving for scholarly journals.
  • COPE Guidelines for Peer Reviewers.
  • Reviewers invited: Eminent professionals are invited to join JAPS reviewer panel. Interested candidates may send their applications to editor@japsonline.com

Home > Past Issue

Journal of Applied Pharmaceutical Science Volume: 6, Issue: 9, September, 2016
DOI: 10.7324/JAPS.2016.60927
ISSN 2231-3354

Research Article

Preclinical safety assessment of glycosides based standardized fenugreek seeds extract: Acute, subchronic toxicity and mutagenicity studies

Pallavi Deshpande, Vishwaraman Mohan, Prasad Thakurdesai

[Download PDF]


Objective: To evaluate acute oral toxicity (AOT), subchronic toxicity, and mutagenic potential of glycosides based standardized fenugreek (Trigonella foenum graecum L.) seeds extract (SFSE-G). Materials and Methods: The AOT, subchronic (90-day repeated dose) toxicity and mutagenicity (reverse mutation test) of oral administration of SFSE-G were evaluated using Sprague-Dawley (SD) rats as per OECD guideline no. 423, No. 408 and 471 respectively. Results: The SFSE-G did not show mortality or treatment-related adverse signs during acute (limit dose of 2000 mg/kg) and subchronic (90-days repeated dose of 250, 500 and 1000 mg/kgwith 28 days of recovery period) administration. The SFSE-G showed oral median lethal dose (LD50) more than 2000 mg/kg during AOT study. The no-observed adverse effect level (NOAEL) of SFSE-G was 1000 mg/kg in male rats and 500 mg/kg in female rats during subchronic toxicity study. Furthermore, SFSE-G did not show mutagenic potential in vitro. Conclusions: SFSE-G was found safe for acute and subchronic (90 days repeated dose) administration in rats with no mutagenic potential.

Keywords: Fenugreek seeds; glycosides; acute oral toxicity; subchronic toxicity; Mutagenicity; rats.